Clinical Topics & News
Conference Coverage
Cognitive behavioral therapy app lowers A1c in type 2 diabetes
People with type 2 diabetes who used a smartphone app for cognitive behavioral therapy had a significant drop in their A1c levels.
News
Guideline stresses new strategies for hypoglycemia management
The latest guideline from The Endocrine Society updates recommendations to reflect new treatment options for hypoglycemia prevention and treatment...
News
Gestational hypertension-diabetes combo signals CVD risk
Having both hypertensive disorders and diabetes while pregnant ups later cardiovascular risk, suggesting greater care is needed when these...
News
The TikTok trend that triggered a diabetes drug shortage
Variety dubbed Ozempic “the worst kept secret in Hollywood – especially given that its most enthusiastic users are not prediabetic and do not...
News
Both potatoes and beans reduced insulin resistance, weight in controlled study
Randomized trial showed similar effects on insulin resistance and weight after 8 weeks of a potato-based or bean-based diet.
News
New genetic variant linked to maturity-onset diabetes of the young
The reported variant in Greenlandic Inuit individuals has the largest population impact of any previously reported variant within a MODY gene.
News
Will ICER review aid bid for Medicare to pay for obesity drugs?
An influential group urges both a reduction in costs of certain obesity medicines and expanded insurance coverage of them. The recommendations are...
News
Night lights in the city link to increased risk of diabetes
Impairment in glucose homeostasis and indicators of diabetes were significantly correlated with higher amounts of exposure to outdoor artificial...
News
Patients complain some obesity care startups offer pills, and not much else
A wave of startups offer access to a new category of weight-loss drugs coupled with intensive behavioral coaching online. But already concerns are...
Conference Coverage
Statins boost glycemia slightly, but CVD benefits prevail
Meta-analysis of 23 trials confirmed statins raise glycemia and can trigger diabetes, but the effect pales compared with their CVD prevention.